Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Biorxiv : the Preprint Server for Biology|September 30, 2024
LiverMap pipeline for 3D imaging of human liver reveals volumetric spatial dysregulation of cirrhotic vasculobiliary architectureWesley B Fabyan, Chelsea L Fortin, Heidi L Kenerson, et al.
The American Journal of Surgical Pathology|April 6, 2019
Validation of a Congestive Hepatic Fibrosis Scoring SystemDustin E Bosch, Konstantin Koro, Elizabeth Richards, et al.
Histopathology|March 25, 2018
Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)Alastair D Burt, Venâncio Alves, Pierre Bedossa, et al.
Plos One|May 6, 2014
Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatmentKendall C Shibuya, Vikas K Goel, Wei Xiong, et al.
The American Journal of Gastroenterology|March 23, 2016
Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB?James E Nelson, Christian L Roth, Laura A Wilson, et al.
Hepatology Communications|November 24, 2021
Pcsk9 Deletion Promotes Murine Nonalcoholic Steatohepatitis and Hepatic Carcinogenesis: Role of CholesterolGeorge N Ioannou, Sum P Lee, Peter S Linsley, et al.
World Journal of Hepatology|June 19, 2015
Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experienceMatthew M Yeh, Raymond S Yeung, Smith Apisarnthanarax, et al.
Hepatology Communications|February 7, 2018
The selective peroxisome proliferator-activated receptor-delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese miceFahrettin Haczeyni, Hans Wang, Vanessa Barn, et al.
Hepatology (Baltimore, Md.)|July 27, 2007
Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunctionDeborah L Diamond, Jon M Jacobs, Bryan Paeper, et al.
Journal of Gastroenterology and Hepatology|February 20, 2009
Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expressionGeoffrey C Farrell, Claire Z Larter, Jing Yun Hou, et al.
Pageof 18